D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 19,634 253 World Ranking 10569 National Ranking 5649

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Alfred A. Bartolucci mostly deals with Internal medicine, Surgery, Prospective cohort study, Lung cancer and Randomized controlled trial. He has researched Internal medicine in several fields, including Gastroenterology, Lupus erythematosus and Endocrinology. His study in Surgery is interdisciplinary in nature, drawing from both Cancer, Magnetic resonance imaging and Melanoma.

His Prospective cohort study study combines topics in areas such as Survival rate, Predictive value of tests and Staining. His Lung cancer study is concerned with the larger field of Oncology. His studies deal with areas such as Diabetes mellitus, Meta-analysis, Asymptomatic, Myocardial infarction and Aspirin as well as Randomized controlled trial.

His most cited work include:

  • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials (2469 citations)
  • Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. (529 citations)
  • Stress, appraisal, coping, and social support as predictors of adaptational outcome among dementia caregivers. (500 citations)

What are the main themes of his work throughout his whole career to date?

Alfred A. Bartolucci mainly investigates Internal medicine, Surgery, Cancer, Chemotherapy and Oncology. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology. His Gastroenterology research includes elements of Regimen, Toxicity and Performance status.

His study looks at the relationship between Surgery and topics such as Melanoma, which overlap with Adjuvant. His research is interdisciplinary, bridging the disciplines of Pathology and Chemotherapy. His Cyclophosphamide research incorporates elements of Combination chemotherapy, Methotrexate and Doxorubicin.

He most often published in these fields:

  • Internal medicine (44.90%)
  • Surgery (27.07%)
  • Cancer (18.15%)

What were the highlights of his more recent work (between 2006-2020)?

  • Statistics (7.64%)
  • Meta-analysis (3.82%)
  • Internal medicine (44.90%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Statistics, Meta-analysis, Internal medicine, Random effects model and Disease. The Meta-analysis study combines topics in areas such as Sample size determination, Randomized controlled trial, Surgery, Raw data and Knowledge base. Alfred A. Bartolucci usually deals with Internal medicine and limits it to topics linked to Cardiology and Cardiac index.

His studies in Random effects model integrate themes in fields like Physical medicine and rehabilitation, Bayesian probability, Markov chain Monte Carlo, Covariate and Multiple sclerosis. His research in Disease intersects with topics in Observed Survival, Ovarian cancer and Proportional hazards model. His Sepsis research includes themes of Increased risk and Oncology.

Between 2006 and 2020, his most popular works were:

  • Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances (186 citations)
  • Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. (127 citations)
  • Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. (125 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Alfred A. Bartolucci spends much of his time researching Meta-analysis, Dementia, Finance, Cognitive disorder and Internal medicine. His work carried out in the field of Meta-analysis brings together such families of science as Hemorrhagic complication, Randomized controlled trial, Confidence interval, Ventriculostomy and Prospective cohort study. His research integrates issues of Myocardial infarction, Program evaluation, Aggression and Behavior change in his study of Randomized controlled trial.

The concepts of his Dementia study are interwoven with issues in Longitudinal study and Physical therapy. Alfred A. Bartolucci has included themes like Alzheimer's disease and Activities of daily living in his Finance study. His Internal medicine research incorporates themes from Diabetes mellitus and Cardiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

W Alberti;G Anderson;A Bartolucci;D Bell.
Lung Cancer (1996)

3997 Citations

Stress, appraisal, coping, and social support as predictors of adaptational outcome among dementia caregivers.

William E. Haley;Ellen G. Levine;S. Lane Brown;Alfred A. Bartolucci.
Psychology and Aging (1987)

983 Citations

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist.
Annals of Surgery (1996)

792 Citations

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Charles M. Balch;Marshall M. Urist;Constantine P. Karakousis;Thomas J. Smith.
Annals of Surgery (1993)

709 Citations

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.

Catherine Marin DeUgarte;Catherine Marin DeUgarte;Alfred A. Bartolucci;Ricardo Azziz;Ricardo Azziz;Ricardo Azziz.
Fertility and Sterility (2005)

630 Citations

Pressure ulcer risk factors among hospitalized patients with activity limitation

Richard M. Allman;Patricia S. Goode;Martha M. Patrick;Nickie Burst.
JAMA (1995)

499 Citations

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

W. R. Vogler;E. Velez-Garcia;R. S. Weiner;M. A. Flaum.
Journal of Clinical Oncology (1992)

495 Citations

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.

Haakon Ragde;Abdel-Aziz A. Elgamal M.D.;Peter B. Snow;Jeff Brandt.
Cancer (1999)

479 Citations

Prognosis in systemic lupus erythematosus

John D. Reveille;Alfred Bartolucci;Graciela S. Alarcón.
Arthritis & Rheumatism (1990)

460 Citations

The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer

Robert James Cerfolio;Buddhiwardhani Ojha;Ayesha S. Bryant;Vanguru Raghuveer.
The Annals of Thoracic Surgery (2004)

443 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alfred A. Bartolucci

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 132

Ricardo Azziz

Ricardo Azziz

University of Alabama at Birmingham

Publications: 111

John D. Reveille

John D. Reveille

The University of Texas Health Science Center at Houston

Publications: 79

Gerald McGwin

Gerald McGwin

University of Alabama at Birmingham

Publications: 59

R. Shane Tubbs

R. Shane Tubbs

Tulane University

Publications: 56

Robert J. Cerfolio

Robert J. Cerfolio

University of Alabama at Birmingham

Publications: 54

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 53

Douglas S. Reintgen

Douglas S. Reintgen

University of South Florida

Publications: 47

Daniel C. Marson

Daniel C. Marson

University of Alabama at Birmingham

Publications: 45

Giorgio V. Scagliotti

Giorgio V. Scagliotti

University of Turin

Publications: 42

Chandra P. Belani

Chandra P. Belani

Penn State Cancer Institute

Publications: 41

Donald L. Morton

Donald L. Morton

Saint John's Health Center

Publications: 41

John F. Thompson

John F. Thompson

University of Sydney

Publications: 41

Silvia Novello

Silvia Novello

University of Turin

Publications: 37

Timothy R. Elliott

Timothy R. Elliott

Texas A&M University

Publications: 36

Roy C. Martin

Roy C. Martin

University of Alabama at Birmingham

Publications: 35

Trending Scientists

François Murat

François Murat

Sorbonne University

Yongdong Zhang

Yongdong Zhang

University of Science and Technology of China

Armando Rastelli

Armando Rastelli

Johannes Kepler University of Linz

Cinzia Casiraghi

Cinzia Casiraghi

University of Manchester

E. K. Khusnutdinova

E. K. Khusnutdinova

Russian Academy of Sciences

Zubair M. Ahmed

Zubair M. Ahmed

University of Maryland, Baltimore

Lorraine J. Gudas

Lorraine J. Gudas

Cornell University

Sandra L. Schmid

Sandra L. Schmid

The University of Texas Southwestern Medical Center

Tobias Bolch

Tobias Bolch

University of St Andrews

Paula Kankaala

Paula Kankaala

University of Eastern Finland

Jacob Nattermann

Jacob Nattermann

University Hospital Bonn

Todd A. Fehniger

Todd A. Fehniger

Washington University in St. Louis

Rickey E. Carter

Rickey E. Carter

Mayo Clinic

Folkert Kuipers

Folkert Kuipers

University Medical Center Groningen

Mariano Sanz

Mariano Sanz

Complutense University of Madrid

Carla J. Berg

Carla J. Berg

George Washington University

Something went wrong. Please try again later.